Bioorganic and Medicinal Chemistry Letters p. 163 - 168 (1997)
Update date:2022-08-03
Topics:
Cherney, Robert J.
Swartz, Stephen G.
Patten, Arthur D.
Akamike, Emeka
Sun, Jung-Hui
Kaltenbach III, Robert F.
Seitz, Steven P.
Behrens, Carl H.
Getahun, Zelleka
Trainor, George L.
Vavala, Mike
Kirshenbaum, Mindy R.
Papp, Lisa M.
Stafford, Margaret P.
Czerniak, Philip M.
Diamond, Richard J.
McRipley, Ronald J.
Page, Roni J.
Gross, Janet L.
Unsymmetrical bis-imides 1 were synthesized and evaluated as potential antitumor agents. These novel bis-imides were assessed using three criteria: in vitro cytotoxicity (L1210), in vitro DNA binding, and in vivo studies with human tumor xenografts in mice. These studies identified DMP 315 as a potent, water soluble antitumor agent.
View Morewebsite:http://www.chinabarton.com
Contact:+86-573-82719618
Address:No. 162 Fumin Road, Honghe Town,
Wuhan Zenuo Biological Medicine Technology Co Ltd
website:http://www.znobio.com/a/lianxiwomen/
Contact:(+86-27)8700-2750
Address:Floor 19th,No.76,Longyang Road
Contact:18710867521(wechat)
Address:Rm10516,Galaxy Tech Building #2,No.25 Tangyan Rd,Hi-Tech Zone,Xi'an, China
Nanjing Qirui Material Co., Ltd.
Contact:+86-25-52320053
Address:F4-5, #17 Building, Chuang Yi Yuan, No.6 Guanghua East Street, Nanjing, 210007 P.R.China
Xi'an Kaixiang Photoelectric Technology Co., Ltd
website:http://www.kxmaterials.com/
Contact:86-29-15991651477
Address:Building 6, Biopharmaceutical Industry R&D Cluster Base, No. 16, Caotang 4th Road, Caotang Science and Technology Industrial Base, High-tech Zone, Xi'an City, Shaanxi Province, China
Doi:10.1021/ja00512a045
(1979)Doi:10.13005/ojc/310168
(2015)Doi:10.1039/P19790001729
(1979)Doi:10.1021/ja01500a026
(1960)Doi:10.1007/s11164-015-2373-y
(2016)Doi:10.1016/S0040-4039(01)80784-X
(1989)
